Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2005309606 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Mastracchio, Anthony; Edmondson, Scott D.; Cox, Jason M.

Agent Spruson & Ferguson

Pub. Number AU-B-2005309606

PCT Pub. Number WO2006/058064

Priority 60/631,517 29.11.04 US

Filing date 22 November 2005

Wipo publication date 1 June 2006

Acceptance publication date 6 January 2011

International Classifications

C07D 471/02 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/058064 Priority application(s): WO2006/058064

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

6 January 2011 Application Accepted

  Published as AU-B-2005309606

12 May 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309616-Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases

2005309605-2,3,4-substituted-cyclopentanones as therapeutic agents